Karolinska Institutet is one of the world´s leading medical universities. Its mission is to contribute to the improvement of human health through research and education. The Nobel Assembly at Karolinska Institutet selects the Nobel laureates in Physiology or Medicine.
Our role in EAVI2020 will be to perform in-depth analyses of germline and antigen-specific antibody repertoires in vaccinated subjects through antibody isolation and deep sequencing.http://ki.se/research/karlsson-hedestam
Gunilla Karlsson Hedestam
Gunilla Karlsson Hedestam is a Professor at Karolinska Institutet in Stockholm. She received her undergraduate training at Uppsala University and a D.Phil. from Oxford University in 1993. She was subsequently a post-doctoral fellow at Harvard Medical School during 1994-1998 where she investigated neutralization properties of primary HIV-1 isolates and developed the simian-human immunodeficiency virus (SHIV) model for pathogenesis studies. After a period in the private sector, she returned to academia and established her group at Karolinska Institutet. She is a member of the International AIDS Vaccine Initiative Neutralizing Antibody Consortium since 2008 and she holds an NIH HIVRAD grant since 2014. Her research focuses on basic B cell biology, in particular immunization-induced responses and the genetics of antibody repertoires.